David Meiri
Impact in
- Pharmacology top 1%
- Cannabis and Cannabinoid Research
- Toxicology top 5%
Papers in
- Pharmacology 44
- Cannabis and Cannabinoid Research 44
-
- Protein Kinase Regulation and GTPase Signaling 5
- Co-authors
- Adina Breiman (4 shared papers)Paula Berman (15 shared papers)Gil M. Lewitus (16 shared papers)Maya Benami (2 shared papers)Robert Rottapel (7 shared papers)Dzmitry Mukha (1 shared paper)Tomer Shlomi (1 shared paper)Adi Avni (2 shared papers)
- Journals
- Journal of Crohn s and Colitis (3 papers)International Journal of Molecular Sciences (3 papers)Frontiers in Pharmacology (3 papers)Scientific Reports (2 papers)Nature Communications (2 papers)
- Partner nations
- IsraelCanadaUnited States
In The Last Decade
David Meiri
58 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 122
- Pharmacology 863
- Toxicology 71
- Plant Science 561
- Biological Psychiatry 31
- Cell Biology 177
Countries citing papers authored by David Meiri
This map shows the geographic impact of David Meiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Meiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Meiri more than expected).
Fields of papers citing papers by David Meiri
This network shows the impact of papers produced by David Meiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Meiri. The network helps show where David Meiri may publish in the future.
Co-authors
The 25 scholars most cited alongside David Meiri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 208 | |
| 2 | 2009 | 196 | |
| 3 | 2019 | 109 | |
| 4 | 2009 | 84 | |
| 5 | 2020 | 84 | |
| 6 | 2010 | 80 | |
| 7 | 2014 | 76 | |
| 8 | 2012 | 75 | |
| 9 | 2019 | 72 | |
| 10 | 2009 | 60 | |
| 11 | 2019 | 60 | |
| 12 | 2015 | 54 | |
| 13 | 2014 | 51 | |
| 14 | 2020 | 42 | |
| 15 | 2021 | 39 | |
| 16 | 2012 | 35 | |
| 17 | 2022 | 32 | |
| 18 | 2020 | 31 | |
| 19 | 2021 | 30 | |
| 20 | 2020 | 26 |
About David Meiri
David Meiri is a scholar working on Pharmacology, Molecular Biology, Plant Science, Cognitive Neuroscience and Cell Biology, having authored 66 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (44 papers), GABA and Rice Research (11 papers), Sleep and related disorders (7 papers), Sleep and Wakefulness Research (7 papers), Dietary Effects on Health (5 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Psychedelics and Drug Studies (4 papers) and Biochemical Analysis and Sensing Techniques (4 papers). The work is most often cited by research in Pharmacology (863 citations), Toxicology (71 citations), Plant Science (561 citations), Biological Psychiatry (31 citations) and Cell Biology (177 citations). David Meiri has collaborated with scholars based in Israel, Canada and United States. Frequent co-authors include Adina Breiman, Paula Berman, Gil M. Lewitus, Maya Benami, Robert Rottapel, Dzmitry Mukha, Tomer Shlomi, Adi Avni, Gil Bar‐Sela and José LaRose. Their work appears in journals such as Journal of Crohn s and Colitis, International Journal of Molecular Sciences, Frontiers in Pharmacology, Scientific Reports and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.